Carson Wealth (CWM LLC)
ALXN

Carson Wealth (CWM LLC)’s Alexion Pharmaceuticals ALXN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$54K Hold
293
– – ﹤0.01% 1374
2021
Q1 		$54K Hold
293
– – ﹤0.01% 1374
2020
Q4 		$54K Hold
293
– – ﹤0.01% 1374
2020
Q3 		$54K Hold
293
– – ﹤0.01% 1373
2020
Q2 		$54K Hold
293
– – ﹤0.01% 1373
2020
Q1 		$54K Hold
293
– – ﹤0.01% 1373
2019
Q4 		$54K Hold
293
– – ﹤0.01% 1373
2019
Q3 		$54K Hold
293
– – ﹤0.01% 1373
2019
Q2 		$54K Hold
293
– – ﹤0.01% 1373
2019
Q1 		$54K Buy
293
+191
+187% +$23.8K ﹤0.01% 1373
2018
Q4 		$10K Sell
102
-41
-29% -$4.85K ﹤0.01% 1349
2018
Q3 		$20K Buy
143
+7
+5% +$878 ﹤0.01% 959
2018
Q2 		$17K Sell
136
-33
-20% -$3.86K ﹤0.01% 879
2018
Q1 		$19K Buy
169
+33
+24% +$3.94K ﹤0.01% 721
2017
Q4 		$16K Hold
136
– – ﹤0.01% 758
2017
Q3 		$19K Buy
136
+93
+216% +$12.6K ﹤0.01% 721
2017
Q2 		$5K Hold
43
– – ﹤0.01% 897
2017
Q1 		$5K Sell
43
-45
-51% -$5.8K ﹤0.01% 882
2016
Q4 		$11K Buy
+88
New +$10.8K ﹤0.01% 717
2014
Q1 		– Sell
-68
Closed -$9K – 536
2013
Q4 		$9K Buy
68
+37
+119% +$4.44K ﹤0.01% 465
2013
Q3 		$4K Buy
+31
New +$3.4K ﹤0.01% 404

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ALXN Position: Q2 2021 in Review

Carson Wealth (CWM LLC) held its Alexion Pharmaceuticals (ALXN) position steady in Q2 2021 at 293 shares worth $54K. The position accounts for ﹤0.01% of the portfolio, ranked #1374.

Carson Wealth (CWM LLC) first reported a position in ALXN in Q3 2013 and has held it in 21 quarters since. 710 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Carson Wealth (CWM LLC) held 293 shares of Alexion Pharmaceuticals worth $54K as of Q2 2021.
  • Carson Wealth (CWM LLC) left its Alexion Pharmaceuticals share count unchanged in Q2 2021.
  • Alexion Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q2 2021, its #1374 holding.
  • Carson Wealth (CWM LLC) first reported a position in Alexion Pharmaceuticals in Q3 2013 and has held it in 21 quarters since.
  • 710 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2021, filed 29 Jul 2021.